Table 5.
Specification | Pubs in Yrs 1–5 | Citations in Yrs 1–5 | NIH funding in Yrs 6–10 (/$100,000) |
---|---|---|---|
(1) Baseline | 0.79 (0.98) | 33.79 (62.18) | 6.48** (1.79) |
(2) No covariates | −2.29 (1.51) | −79.20 (73.80) | 4.57** (2.03) |
(3) Including Institutes with Few Grants or Higher Error Rates | 0.84 (0.98) | 33.10 (62.41) | 6.73** (1.82) |
(4) Restricting Sample to Institutes with Lower Error Rates | 0.45 (1.21) | 5.36 (80.40) | 7.43** (2.12) |
(5) Dropping Observations at Cutoff | 0.62 (0.91) | 7.65 (59.24) | 6.49** (1.68) |
(6) Using Observations within 100 Points of Cutoff | 0.67 (2.72) | 353.93** (177.08) | 14.62** (4.84) |
(7) Using Observations within 150 Points of Cutoff | 0.81 (1.44) | 61.64 (90.63) | 6.03** (2.58) |
(8) Using Observations within 250 Points of Cutoff | 0.63 (0.72) | −9.17 (45.73) | 5.46** (1.33) |
(9) Using Observations within 300 Points of Cutoff | 0.68 (0.57) | −45.15 (36.75) | 4.21** (1.03) |
(10) Including only linear term in the rating | −0.30 (0.66) | −164.06** (44.03) | 0.04 (1.30) |
(11) Including 3rd order polynomials in the rating | 0.14 (1.86) | 85.65 (120.56) | 7.42** (3.37) |
(12) Only using Variation Attributable to Cutoff | 1.00 (1.03) | 43.10 (66.10) | 6.90** (1.87) |
Notes: The specifications are identical to those in Table 3 except as indicated.
indicates statistical significance at the 5 percent level;
indicates significance at the 10 percent level.